Bioactive Components in Milk and Dairy Products - Prof. Dr. Aulanni ...

More documents

Recommendations

Info

Larsson , S.C. , Bergkvist , L. , and Wolk , A. 2005 . High - fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish mammography cohort . American Journal Clinical Nutrition 82 : 894 – 900 . Lee , K.W. , and Lee , H.J. 2005 . Role of the conjugated linoleic acid in the prevention cancer . Critical Reviews in Food Science and Nutrition 45 : 135 – 144 . Lindmark - M å nsson , H. , Timgren , A. , Aden , G. , and Paulsson , M. 2005 . Two - dimensional gel electrophoresis of proteins and peptides in bovine milk . International Dairy Journal 15 : 111 – 121 . L ö nnerdal , B. 2003 . Nutritional and physiologic signifi cance of human milk proteins . American Journal of Clinical Nutrition 77 : 1537 S – 1543 S. L ó pez - Exp ó sito , I. , Quir ó s , A. , Amigo , L. , and Recio , I. 2007 . Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides . Lait 87 : 241 – 249 . L ó pez - Exp ó sito , I. , and Recio , I. 2006 . Antibacterial activity of peptides and folding variants from milk proteins . International Dairy Journal 16 : 1294 – 1305 . L ó pez - Fandi ñ o , R. , Otte , J. , and Van Camp , J. 2006 . Physiological, chemical and technological aspects of milk - protein - derived peptides with antihypertensive and ACE - inhibitory activity . International Dairy Journal 16 : 1277 – 1293 . Lorenzen , P.C. , and Meisel , H. 2005 . Infl uence of trypsin action in yoghurt milk on the release of caseinophosphopeptide - rich fractions and physical properties of the fermented products . International Journal of Dairy Technology 58 : 119 – 124 . Lozano , J.M. , Giraldo , G.I. , and Romero , C.M. 2008 . An improved method for isolation of β - lactoglobulin . International Dairy Journal 18 : 55 – 63 . Luhovyy , B.L. , Akhavan , T. , and Anderson , G.H. 2007 . Whey proteins in the regulation of food intake and satiety . Journal of American College of Nutrition 26 : 704 S – 712 S. Madureira , A.R , Pereira , C.I. , Gomes , A.M.P. , Pintado , M.E. , and Malcata , F.X. 2007 . Bovine whey proteins — Overview on their main biological properties . Food Research International 40 : 1197 – 1211 . Maes , W. , van Camp , J. , Vermeirssen , V. , Hemeryck , M. , Ketelslegers , J.M. , Schrezenmeier , J. , Chapter 2: Bioactive Components in Bovine Milk 37 van Oostveldt , P. , and Huyghebaert , A. 2004 . Infl uence of the lactokinin Ala - Leu - Pro - Met - His - Ile - Arg (ALPMHIR) on the release of endothelin - 1 by endothelial cells . Regulatory Peptides 118 : 105 – 109 . Manso , M.A. , and L ó pez - Fandi ñ o , R. 2004 . κ - Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses . Food Reviews International 20 : 329 – 355 . Markus , C.R. , Olivier , B. , and de Haan , E.H. 2002 . Whey protein rich in α - lactalbumin increases the ratio of plasma tryptophan to the sum of the large neutral amino acids and improves cognitive performance in stress - vulnerable subjects . American Journal of Clinical Nutrition 75 : 1051 – 1056 . Markus , C.R. , Olivier , B. , Pamhuysen , G.E. , Van der Gugten , J. , Alles , M - S. , Tuiten , A. , et al. 2000 . The bovine protein α - lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration and improves mood under stress . American Journal of Clinical Nutrition 75 : 1051 – 1056 . Marshall , K. 2004 . Therapeutic applications of whey proteins . Alternative Medicine Review 9 : 136 – 156 . Martin , M.J. , Martin - Sosa , S. , Garcia - Pardo , I.A. , and Hueso , P. 2001 . Distribution of bovine sialoglycoconjugates during lactation . Journal of Dairy Science 84 : 995 – 1000 . Matar , C. , LeBlanc , J.G. , Martin , L. , and Perdig ó n , G. 2003 . Biologically active peptides released in fermented milk: Role and functions . In Handbook of Fermented Functional Foods. Functional Foods and Nutraceuticals Series , edited by E.R. Farnworth . CRC Press , Boca Raton, FL . pp. 177 – 201 . Mather , I.H. 2000 . A review and proposed nomenclature for major proteins of the milk - fat globule membrane . Journal of Dairy Science 83 : 203 – 247 . Matsumoto , H. , Shimokawa , Y. , Ushida , Y. , Toida , T. , and Hayasawa , H. 2001 . New biological function of bovine α - lactalbumin: Protective effect against ethanol - and stress - induced gastric mucosal injury in rats. Bioscience , Biotechnology and Biochemistry 65 : 1104 – 1111 .
38 Section I: Bioactive Components in Milk McDonagh , D. , and FitzGerald , R.J. 1998 . Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations . International Dairy Journal 8 : 39 – 45 . McIntosh , G.H ,, Royle , P.J. , Le Leu , R.K. , Regester , G.O. , Johnson , M.A. , Grinsted , R.L. , Kenward , R.S. , and Smithers , G. 1998 . Whey proteins as functional ingredients? International Dairy Journal 8 : 425 – 434 . Mehra , R. , and Kelly , P. 2006 . Milk oligosaccharides: Structural and technological aspects . International Dairy Journal 16 : 1334 – 1340 . Mehra , R. , Marnila , P. , and Korhonen , H. 2006 . Milk immunoglobulins for health promotion . International Dairy Journal 16 : 1262 – 1271 . Meisel , H. 1998 . Overview on milk protein - derived peptides . International Dairy Journal 8 : 363 – 373 . Meisel , H. . 2005 . Biochemical properties of peptides encrypted in bovine milk proteins . Current Medical Chemistry 12 : 1905 – 1919 . Meisel , H. , and FitzGerald , R.J. 2000 . Opioid peptides encrypted in intact milk protein sequences . British Journal of Nutrition 84 ( Suppl.1 ): 27 – 31 . — — — . 2003 . Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects . Current Pharmaceutical Design 9 : 1289 – 1295 . Mensink , R.P. 2006 . Dairy products and the risk to develop type 2 diabetes or cardiovascular disease . International Dairy Journal 16 : 1001 – 1004 . Mero , A. , K ä hk ó nen , J. , Nyk ó nen , T. , Parviainen , T. , Jokinen , I. , Takala , T. , Nikula , T. , Rasi , S. , and Lepp ä luoto , J. 2002 . IGF - 1, IgA and IgG responses to bovine colostrum supplementation during training . Journal of Applied Physiology 93 : 732 – 739 . Michaelidou , A. , and Steijns , J. 2006 . Nutritional and technological aspects of minor bioactive components in milk and whey: Growth factors, vitamins and nucleotides . International Dairy Journal 16 : 1421 – 1426 . Mizuno , S. , Nishimura , S. , Matsuura , K. , Gotou , T. , and Yamamoto , N. 2004 . Release of short and proline - rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease . Journal of Dairy Science 87 : 3183 – 3188 . Mullally , M. M. , Meisel , H. , and FitzGerald , R.J. 1997 . Identifi cation of a novel angiotensin - I - converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β - lactoglobulin . FEBS Letters 402 : 99 – 101 . Mulvihill , D.M. , and Ennis , M.P. 2003 . Functional milk proteins: production and utilization . In Advances in Dairy Chemistry , Vol 1: Proteins, edited by P.F. Fox and P.L.H. McSweeney . Kluwer Academic/Plenum Publishers , New York . pp. 1175 – 1228 . Murakami , M. , Tonouchi , H. , Takahashi , R. , Kitazawa , H. , Kawai , Y. , Negishi , H. , et al. 2004 . Structural analysis of a new anti - hypertensive peptide ( β - lactosin B) isolated from a commercial whey product . Journal of Dairy Science 87 : 1967 – 1974 . Murray , B.A. , and Fitzgerald , R.J. 2007 . Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production . Current Pharmaceutical Design 13 : 773 – 91 . Nagaoka , S. , Futamura , Y. , Miwa , K. , Awano , T. , Yamauchi , K. , Kanamaru , Y. , Tadashi , K. , and Kuwata , T. 2001 . Identifi cation of novel hypocholesterolemic peptides derived from bovine milk β - lactoglobulin . Biochemical and Biophysical Research Communications 218 : 11 – 17 . Nakamura , Y. , Yamamoto , M. , Sakai , K. , Okubo , A. , Yamazaki , S. , and Takano , T. 1995 . Purifi cation and characterization of angiotensin I - converting enzyme inhibitors from sour milk . Journal of Dairy Science 78 : 777 – 783 . O ’ Donnell , R. , Holland , J.W. , Deeth , H.C. , and Alewood , P. 2004 . Milk proteomics . International Dairy Journal 14 : 1013 – 1023 . Ong , L. , Henriksson , A. , and Shah , N.P. 2007 . Angiotensin converting enzyme - inhibitory activity in cheddar cheeses made with the addition of probiotic Lactobacillus casei sp . Lait 87 : 149 – 165 . Otte , J. , Shalaby , S.M. , Zakora , M. , Pripp , A.H. , and El - Shabrawy , S.A. 2007 . Angiotensin - converting enzyme inhibitory activity of milk protein hydrolysates: Effect of substrate, enzyme and time of hydrolysis . International Dairy Journal 17 : 488 – 503 . Pakkanen , R. , and Aalto , J. 1997 . Growth factors and antimicrobial factors of bovine colostrum . International Dairy Journal 7 : 285 – 297 . Pan , Y. , Lee , A. , Wan , J. , Coventry , M.J. , Mixchalski , W.P. , Shiell , B. , and Roginski , H. 2006 . Anti-
Page 1 and 2: Bioactive Components Milk in Dairy
Page 4 and 5: Bioactive Components in Milk and Da
Page 6 and 7: Contributors vii Foreword xi Table
Page 8 and 9: Ryozo Akuzawa Department of Food Sc
Page 10: Peter Williams Smart Foods Centre U
Page 14: Bioactive Components in Milk and Da
Page 17 and 18: 4 Overview of Bioactive Components
Page 19 and 20: 6 Table 1.2. Examples of physiologi
Page 28 and 29: INTRODUCTION 2 Bioactive Components
Page 30 and 31: contribute signifi cantly to daily
Page 32 and 33: identifi ed a large number of minor
Page 34 and 35: peptide β - lactosin B [Ala - Leu
Page 36 and 37: tional. The natural concentrations
Page 38 and 39: Chapter 2: Bioactive Components in
Page 40 and 41: BIOACTIVE LIPIDS Bovine milk fat is
Page 42 and 43: 2006 ). The wide range of CLA value
Page 44 and 45: and epithelial cells. Both forms of
Page 46 and 47: REFERENCES Abd El - Salam , M.H. ,
Page 48 and 49: Fong , B.Y. , Norris , C.S. , and P
Page 52 and 53: viral properties of milk proteins a
Page 54 and 55: Smithers , G.W. 2004 . Isolation of
Page 56 and 57: 3 Bioactive Components in Goat Milk
Page 58 and 59: goat milk cheese. In another study,
Page 60 and 61: dB Buffering index ( ) dpH 0.09 0.0
Page 62 and 63: Antihypertensive Antioxidative Anti
Page 64 and 65: Chapter 3: Bioactive Components in
Page 66 and 67: Cytomodulatory Peptides There is in
Page 68 and 69: SBP, mmHg 220 200 180 160 140 ACE -
Page 70 and 71: e greater than the sum of the indiv
Page 72 and 73: in goat milk fat by feeding special
Page 74 and 75: intake of dietary cholesterol, as w
Page 76 and 77: ifi dus growth promoter, and it has
Page 78 and 79: ferrin can retain iron at very low
Page 80 and 81: solubility by the fermentation of u
Page 82 and 83: Major Minerals Calcium Calcium is a
Page 84 and 85: BIOACTIVE VITAMINS IN GOAT MILK Vit
Page 86 and 87: Edgar , W.M. 1993 . Extrinsic and i
Page 88 and 89: Pariza , and G.J. Nelson , eds. Ame
Page 90 and 91: Meisel , H. , and Schlimme , E. 199
Page 92 and 93: Regester , G.O. , Smithers , G.W. ,
Page 94: T.J. 1998 . Lactoferricin of bovine
Page 97 and 98: 84 Section I: Bioactive Components
Page 99 and 100: 86 Section I: Bioactive Components
Page 101 and 102:
88 Section I: Bioactive Components
Page 103 and 104:
Page 105 and 106:
92 Table 4.5. Sequence of bioactive
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
114 Table 5.6. N - terminal sequenc
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 172 and 173:
INTRODUCTION 6 Bioactive Components
Page 174 and 175:
milk, respectively. This ratio is i
Page 176 and 177:
The amino acid compositions of came
Page 178 and 179:
Recently, acid whey prepared from c
Page 180 and 181:
Table 6.5. The average concentratio
Page 182 and 183:
Chapter 6: Bioactive Components in
Page 184 and 185:
ound amino acids in camel milk are
Page 186 and 187:
Lactoferrin The inhibition effect o
Page 188 and 189:
for 2 or 3 days; in this type, skin
Page 190 and 191:
proteins are different in their com
Page 192 and 193:
and lower content of short - chain
Page 194 and 195:
Spitsberg 2005 ). Meanwhile, it has
Page 196 and 197:
IGF - binding proteins (IGFBP 1 - 6
Page 198 and 199:
Vitamin E is also low in camel milk
Page 200 and 201:
Carlsson , A. , Bjorck , L. , and P
Page 202 and 203:
FAO/WHO/UNU Expert Consultation . 1
Page 204 and 205:
ovi , S. , Pekkanen , J. , Pekkarin
Page 206 and 207:
experience and feeding patterns of
Page 208 and 209:
7 Bioactive Components in Mare Milk
Page 210 and 211:
Mare milk is quite similar to human
Page 212 and 213:
Table 7.4. The vitamin contents of
Page 214 and 215:
α - lactalbumin can interact with
Page 216 and 217:
Carbohydrate Lactose is found in th
Page 218 and 219:
cow milk, because IGF - Is in mare
Page 220 and 221:
et al. (1986) once used natural mar
Page 222 and 223:
De Oliveira , I.R. , de Araujo , A.
Page 224 and 225:
Marconi , E. , and Panfi li , G. 19
Page 226:
Summer , A. , Sabbioni , A. , Forma
Page 230 and 231:
8 Bioactive Components in Caseins,
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
223 Table 8.6. Immunomodulating and
Page 238 and 239:
Page 240 and 241:
Other Bioactive Components in Chees
Page 242 and 243:
Page 244 and 245:
Page 246:
Page 249 and 250:
236 Section II: Bioactive Component
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
272 Table 11.5. Continued Component
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 300 and 301:
12 Probiotics and Prebiotics as Bio
Page 302 and 303:
Chapter 12: Probiotics and Prebioti
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
therapeutic use. Stimulating agents
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324:
Section III Other Related Issues on
Page 327 and 328:
314 Section III: Other Related Issu
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 342 and 343:
14 New Technologies for Isolation a
Page 344 and 345:
Chapter 14: New Technologies for Is
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 392 and 393:
17 Potential for Improving Health:
Page 394 and 395:
Chapter 17: Potential for Improving
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Serum iron μg/gl 500 400 300 200 1
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Abdominal, 44, 256, 295 bloating, 2
Page 412 and 413:
Antiinfl ammatory, 129, 240, 242 ac
Page 414 and 415:
IgG, 351 lactoperoxidase, 170 oligo
Page 416 and 417:
Child, 379 bearing age, 379 Childre
Page 418 and 419:
Defatting, 330 Defi cient, 379 Defi
Page 420 and 421:
Ewe milk, 60 fat, 60 Exercise, 368
Page 422 and 423:
Glandular, 43, 352 derived, 43 epit
Page 424 and 425:
Hyperchylomicronemia, 128 Hyperimmu
Page 426 and 427:
supplemented formula, 381 supplemen
Page 428 and 429:
Madagascar, 48 Magnesium, 68, 130,
Page 430 and 431:
Negative, 380 calcium balance, 367
Page 432 and 433:
Pathophysiological, 121, 238 factor
Page 434 and 435:
Propionibacteria, 29 Proposition, 3
Page 436 and 437:
Skim milk, 49, 115, 206, 217, 379 c
Page 438 and 439:
Toxins, 20 Toxoplasma gondii, 21 Tr
show all

Bioactive Components in Milk and Dairy Products - Prof. Dr. Aulanni ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?